Company Overview
India Glycols Limited manufactures and sells bio-based specialities and performance chemicals in India and internationally. It operates through Bio-based Specialities and Performance Chemicals, Potable Spirits, Ennature Biopharma, and Bio-Fuel segments. The company offers bio mono ethylene, di ethylene, and tri ethylene glycols; ethylene and diethylene glycol monoethyl ethers, ethylene and diethylene glycol monoethyl ether acetates, and brake fluids; biopolymers from agricultural guar gum, tamarind gum, and cassia gum; biofuels, which include ethanol, DDGS, and DWGS; specialty chemicals, such as plasticizers, oil fields chemicals, bioamines, methyl soyate, methyl diethanolamine (MDEA) and MDEA derivatives, bio-potash granules, and C-Smart specialty products; molasses-based and grain-based extra neutral alcohol; and specialty gases, including industrial and medical oxygen, food grade and industrial carbon dioxide, liquid argon and nitrogen, ethylene oxide, and bio ethylene oxide. It also provides Indian made foreign liquor, such as whiskey under Soulmate Blu and Single Reserve brands; vodka under the Amazing Vodka brand; rum under Zumba Lemoni Citrus, Zumba Black Spiced, and Beach House XXX brands; economy spirits under Bunty brand; and branded country liquor. In addition, the company offers active pharmaceutical ingredients, branded nutraceutical ingredients, standardized botanical extracts, and nicotine derivatives. It serves the pharma and healthcare; textiles; automotive; personal care; industrial and manufacturing; paints and coatings; oil and gas; food ingredients; packaging; potable spirits; and other various industries, as well as corporates, medium and small enterprises, traders, and distributors. The company exports its products. The company was formerly known as UP Glycols Limited and changed its name to India Glycols Limited in August 1986. India Glycols Limited was incorporated in 1983 and is headquartered in Noida, India.
Why Investors Should Care
Net profit has compounded at 32.8% per year over the last five years.
Revenue has grown at a 17.8% CAGR over the past five years.
Trades at a P/E of 7.0, below the sector median of 27.4.
Recent Developments
- Mar 2026 Revenue of ₹4,211.41 Cr (+11.8% YoY); net profit ₹292.76 Cr.
- Trailing 12 Months Year-on-year growth — revenue +11.8%, earnings +26.8%.
- 5-Year Trend Long-term compounding — revenue CAGR 17.8%, profit CAGR 32.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 17.79% |
| 1 Year: | 11.76% |
Compounded Profit Growth
| 5 Years: | 32.77% |
| 1 Year: | 26.78% |
Stock Price Performance
| 1 Year: | -69.22% |
| 6 Months: | -68.92% |
| 3 Months: | -73.38% |
| 1 Month: | -77.38% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)14.16 · Oversold
P/E of 6.98 is below the sector median of 27.43 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 17.8% over 5 years.
- Profit CAGR of 32.8% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 78.4% below its 52-week high.
- RSI at 14 suggests oversold conditions.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | INDIAGLYCO India Glycols Limited NSEINFRA | 260.40 | 6.98 | ₹1,745.38 Cr | 1.09% | 12.07% | 9.98% | 17.79% | 32.77% |
| 2 | ULTRACEMCO UltraTech Cement Limited NIFTY50NSEINFRA | 11,408.00 | 41.12 | ₹3.36 L Cr | 1.99% | 11.84% | 10.66% | 11.92% | 17.26% |
| 3 | JSWSTEEL JSW Steel Limited NIFTY50NSEAIINFRA | 1,325.00 | 14.52 | ₹3.24 L Cr | 0.54% | 18.75% | 22.30% | 3.61% | 75.28% |
| 4 | HINDZINC Hindustan Zinc Limited NSEINFRA | 601.00 | 18.36 | ₹2.54 L Cr | 3.56% | 61.97% | 61.13% | 5.61% | 9.58% |
| 5 | ASIANPAINT Asian Paints Limited NIFTY50NSEINFRA | 2,527.30 | 56.03 | ₹2.42 L Cr | 1.00% | 24.41% | 20.24% | 1.10% | 1.75% |
| 6 | TATASTEEL Tata Steel Limited NIFTY50NSEAIINFRA | 188.79 | 21.83 | ₹2.36 L Cr | 2.11% | 11.32% | 10.56% | -1.59% | 7.21% |
| 7 | HINDALCO Hindalco Industries Limited NIFTY50NSEAIINFRA | 1,011.00 | 16.79 | ₹2.27 L Cr | 0.49% | 9.42% | 9.80% | 7.10% | 9.87% |
| 8 | GRASIM Grasim Industries Limited NIFTY50NSEINFRA | 3,322.00 | 59.86 | ₹2.26 L Cr | 0.31% | 3.98% | 4.80% | 14.30% | -10.06% |
| 9 | SOLARINDS Solar Industries India Limited NSEINFRA | 21,445.00 | 115.68 | ₹1.94 L Cr | 0.06% | 29.51% | 26.72% | 12.39% | 30.36% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 619.00 Cr | 689.00 Cr | 775.00 Cr | 904.00 Cr | 926.00 Cr | 969.00 Cr | 961.00 Cr | - | 863.22 Cr | 1,040.46 Cr | 1,092.20 Cr | 1,102.40 Cr | 976.35 Cr |
| Cost of Revenue | - | - | - | - | - | - | - | - | 533.89 Cr | 677.47 Cr | 685.85 Cr | 691.72 Cr | 606.96 Cr |
| Gross Profit | - | - | - | - | - | - | - | - | 329.33 Cr | 362.99 Cr | 406.35 Cr | 410.68 Cr | 369.39 Cr |
| Operating Expenses | 523.00 Cr | 589.00 Cr | 679.00 Cr | 802.00 Cr | 822.00 Cr | 843.00 Cr | 845.00 Cr | - | 215.98 Cr | 247.80 Cr | 287.19 Cr | 276.43 Cr | 244.12 Cr |
| Operating Income | 66.00 Cr | 79.00 Cr | 68.00 Cr | 76.00 Cr | 79.00 Cr | 98.00 Cr | 88.00 Cr | - | 113.35 Cr | 115.19 Cr | 119.16 Cr | 134.25 Cr | 125.27 Cr |
| EBITDA | 96.00 Cr | 100.00 Cr | 96.00 Cr | 102.00 Cr | 105.00 Cr | 126.00 Cr | 116.00 Cr | - | 158.91 Cr | 169.66 Cr | 171.37 Cr | 178.64 Cr | 180.10 Cr |
| Interest Expense | 26.00 Cr | 28.00 Cr | 29.00 Cr | 31.00 Cr | 33.00 Cr | 36.00 Cr | 40.00 Cr | - | 44.53 Cr | 44.68 Cr | 49.28 Cr | 46.81 Cr | 26.41 Cr |
| Pretax Income | 46.00 Cr | 64.00 Cr | 50.00 Cr | 54.00 Cr | 56.00 Cr | 76.00 Cr | 63.00 Cr | - | 81.79 Cr | 90.53 Cr | 83.61 Cr | 90.61 Cr | 112.46 Cr |
| Tax Provision | 5.98 Cr | 12.80 Cr | 12.00 Cr | 12.42 Cr | 13.44 Cr | 15.20 Cr | 13.86 Cr | - | 17.77 Cr | 17.28 Cr | 18.55 Cr | 23.04 Cr | 25.58 Cr |
| Net Income | 40.00 Cr | 51.00 Cr | 38.00 Cr | 42.00 Cr | 42.00 Cr | 60.00 Cr | 50.00 Cr | - | 64.02 Cr | 73.25 Cr | 65.06 Cr | 67.57 Cr | 86.88 Cr |
| Diluted EPS | 6.51 | 8.26 | 6.14 | 6.73 | 6.82 | 9.75 | 8.03 | - | 10.34 | 11.83 | 10.51 | 10.79 | 13.64 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,579.00 Cr | 2,324.00 Cr | 2,500.00 Cr | 3,034.00 Cr | 3,357.00 Cr | 2,735.00 Cr | 2,317.00 Cr | - | 2,577.02 Cr | 3,293.97 Cr | 3,768.26 Cr | 4,211.41 Cr |
| Cost of Revenue | - | - | - | - | - | - | - | - | 1,631.49 Cr | 2,213.44 Cr | 2,407.85 Cr | 2,662.00 Cr |
| Gross Profit | - | - | - | - | - | - | - | - | 945.53 Cr | 1,055.20 Cr | 1,360.41 Cr | 1,549.41 Cr |
| Operating Expenses | 2,455.00 Cr | 2,149.00 Cr | 2,263.00 Cr | 2,712.00 Cr | 2,941.00 Cr | 2,433.00 Cr | 2,026.00 Cr | - | 711.57 Cr | 736.07 Cr | 964.67 Cr | 1,055.54 Cr |
| Operating Income | 35.00 Cr | 106.00 Cr | 165.00 Cr | 249.00 Cr | 340.00 Cr | 225.00 Cr | 211.00 Cr | - | 233.96 Cr | 319.13 Cr | 395.74 Cr | 493.87 Cr |
| EBITDA | 124.00 Cr | 175.00 Cr | 237.00 Cr | 322.00 Cr | 416.00 Cr | 303.00 Cr | 291.00 Cr | - | 343.98 Cr | 429.21 Cr | 571.89 Cr | 699.77 Cr |
| Interest Expense | 163.00 Cr | 139.00 Cr | 127.00 Cr | 125.00 Cr | 143.00 Cr | 97.00 Cr | 83.00 Cr | - | 85.01 Cr | 105.12 Cr | 164.37 Cr | 167.18 Cr |
| Pretax Income | -144.00 Cr | -81.00 Cr | 45.00 Cr | 147.00 Cr | 213.00 Cr | 153.00 Cr | 143.00 Cr | - | 165.01 Cr | 223.31 Cr | 292.32 Cr | 377.21 Cr |
| Tax Provision | 54.72 Cr | 24.30 Cr | 9.90 Cr | 49.98 Cr | 80.94 Cr | 38.25 Cr | 11.44 Cr | - | 23.96 Cr | 50.32 Cr | 61.40 Cr | 84.45 Cr |
| Net Income | -89.00 Cr | -57.00 Cr | 35.00 Cr | 97.00 Cr | 133.00 Cr | 115.00 Cr | 132.00 Cr | - | 125.08 Cr | 172.99 Cr | 230.92 Cr | 292.76 Cr |
| Diluted EPS | -14.32 | -9.18 | 5.66 | 15.59 | 21.42 | 18.52 | 21.26 | 54.88 | 22.77 | 27.93 | 37.29 | - |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 3,154.00 Cr | 3,620.00 Cr | 3,492.00 Cr | 3,421.00 Cr | 3,784.00 Cr | 4,086.00 Cr | 4,119.00 Cr | - | 4,858.33 Cr | 5,616.80 Cr | 6,176.10 Cr | 6,522.95 Cr |
| Current Assets | - | - | - | - | - | - | - | - | 1,646.24 Cr | 1,944.70 Cr | 1,816.22 Cr | 1,497.81 Cr |
| Cash & Equivalents | - | - | - | - | - | - | - | - | 1.97 Cr | 26.96 Cr | 6.84 Cr | 31.87 Cr |
| Inventory | - | - | - | - | - | - | - | - | 753.83 Cr | 1,106.29 Cr | 1,170.88 Cr | 890.61 Cr |
| Receivables | - | - | - | - | - | - | - | - | 430.34 Cr | 384.10 Cr | 364.97 Cr | 351.40 Cr |
| Total Liabilities | - | - | - | - | - | - | - | - | 2,956.91 Cr | 3,565.78 Cr | 3,920.22 Cr | 3,590.17 Cr |
| Current Liabilities | - | - | - | - | - | - | - | - | 1,864.93 Cr | 2,374.73 Cr | 2,321.04 Cr | 2,014.11 Cr |
| Long Term Debt | - | - | - | - | - | - | - | - | 550.77 Cr | 725.08 Cr | 1,040.09 Cr | 919.13 Cr |
| Total Debt | 2,264.00 Cr | 1,236.00 Cr | 1,095.00 Cr | 834.00 Cr | 1,000.00 Cr | 999.00 Cr | 1,137.00 Cr | - | 1,112.27 Cr | 1,348.23 Cr | 1,891.53 Cr | 1,690.61 Cr |
| Total Equity | 297.00 Cr | 718.00 Cr | 752.00 Cr | 845.00 Cr | 963.00 Cr | 1,034.00 Cr | 1,169.00 Cr | - | 1,901.42 Cr | 2,051.02 Cr | 2,255.88 Cr | 2,932.78 Cr |
| Shares Outstanding | - | - | - | - | - | - | - | - | 6.19 Cr | 6.19 Cr | 6.19 Cr | 6.70 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -171.00 Cr | 1,231.00 Cr | 302.00 Cr | 502.00 Cr | 147.00 Cr | 343.00 Cr | 137.00 Cr | - | 325.71 Cr | 438.53 Cr | 362.11 Cr | 769.17 Cr |
| Investing Cash Flow | 175.00 Cr | -78.00 Cr | -40.00 Cr | -103.00 Cr | -128.00 Cr | -151.00 Cr | -148.00 Cr | - | -330.28 Cr | -503.45 Cr | -735.99 Cr | -766.68 Cr |
| Financing Cash Flow | -4.00 Cr | -1,168.00 Cr | -263.00 Cr | -399.00 Cr | 3.00 Cr | -216.00 Cr | 11.00 Cr | - | -50.69 L | 89.91 Cr | 353.76 Cr | 22.54 Cr |
| Capital Expenditure | 118.00 Cr | -94.00 Cr | -42.00 Cr | -129.00 Cr | -138.00 Cr | -150.00 Cr | -148.00 Cr | - | -438.77 Cr | -552.93 Cr | -760.47 Cr | -823.48 Cr |
| Free Cash Flow | -53.00 Cr | 1,137.00 Cr | 260.00 Cr | 373.00 Cr | 9.00 Cr | 193.00 Cr | -11.00 Cr | - | -113.06 Cr | -114.40 Cr | -398.36 Cr | -54.31 Cr |
| Net Change in Cash | -0 | -15.00 Cr | -1.00 Cr | -0 | 22.00 Cr | -23.00 Cr | -0 | - | -5.07 Cr | 24.98 Cr | -20.12 Cr | 25.03 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | 36.7% | 32.0% | 36.1% | 36.8% |
| Operating Margin % | 1.4% | 4.6% | 6.6% | 8.2% | 10.1% | 8.2% | 9.1% | - | 9.1% | 9.7% | 10.5% | 11.7% |
| Net Margin % | -3.5% | -2.5% | 1.4% | 3.2% | 4.0% | 4.2% | 5.7% | - | 4.9% | 5.3% | 6.1% | 7.0% |
| ROE % | -30.0% | -7.9% | 4.7% | 11.5% | 13.8% | 11.1% | 11.3% | - | 6.6% | 8.4% | 10.2% | 10.0% |
| ROCE % | - | - | - | - | - | - | - | - | 7.8% | 9.8% | 10.3% | 11.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for INDIAGLYCO
INDIAGLYCO Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMifkFVX3lxTE1iczd6Qi1TSHk3UUN0by1IQzRFdEgxb0lBQUFscC1vMEtqdjIzWTlIRnp2OTNoODJYNk5taF9sLVNtVkNLTEpRWTVXNlgybk5Na3VWR0RXQ05aLVNpR0FpUFFSNXFOaFAxeFVFLVJNSGZhdlVKMjBsdXE4aXJSZw?oc=5" target="_blan…
Investors Shouldn't Be Too Comfortable With India Glycols' (NSE:INDIAGLYCO) Earnings - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxNM0h2dHRSa2NQT0xFOEJ6VFRUSmNCalFPZkUzNkJxUFBDUjZkLW1KZlhhanhYVExMYl8zQ3pHSWJuMU9hVVlZTGxudjZIWXZxdWU4UVVnUE1vVUFUbzV6d0NtVUFwbC1OZlBTSnZpaDVRRk5BYmp0dTM3Q2RmZ3Z4Y1oxSkx2SjFZc0ZGd3…
India Glycols shares: Why this multibagger stock is showing 80% crash in some trading apps today - Business Today
<a href="https://news.google.com/rss/articles/CBMi9AFBVV95cUxQcDhBZDUwN3A2bWJ0Sm03ZUdFZTVFd1B2MWsxc2x5LWZHeE0yT1lOZVN3cGxhcElKUHFVOEFFc01mNlktWE5zUDlKSzd0SUpGOS1PUXJJUTBaemJQcURhNzRnUHJnTXVwZ0hyblBNMXdXeXhKdkxDeFAxS3J6UEdmRHJGY1lrZmQySXBDYm…
Stock Nears Key Support Amid Weak Chemical Sector Sentiment - Mean Reversion Trade - siam.in
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxONWdSZnYyVGp4bnBhVWVPLVQ3bE1GOG1wSU1WcEpYVnlBSVNmWUI4ZWJBSkV1VXdBMFJEVW1CNkM4NDNVUTh6UUpJbWdaS09KdlVwSzZsMC1IMlBHQXljWnJCTzV1Vng0VHVVSEkzNWVwX3hfNE9wRVRRQWFINTRTdzNoTmxyRkFrZXBYNE…
News by CNBC TV18 on TradingView, 2026-09-02 — cnbctv:857193c89094b:0 - TradingView
<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5jUlR4NlJMcEp6anpyLXNRb2FiY25Yd1Rwa3JYb2t1WHlsd1o4SDhJZnQ4a3RlbElHTk5TMzdTVU5BYmZwdUd4Q1hSTGtVWGNsZWEyby1iTDZvQVAta18wcTFZcktuTkE?oc=5" target="_blank">News by CNBC TV18 on Trading…
INDIAGLYCO Mar 2026 Earnings: Steady Revenue Base and Improved Margins Drive Quarterly Performance - ROIC Trend Report - vinanet.vn
<a href="https://news.google.com/rss/articles/CBMi1gFBVV95cUxNN0s5WmZLWHM0VTk4anBiSmVocHQ0M0g0TXFqSWtWRFdCb3dkUFRPVEhld002bE5kZms5QjFub3pKVmNnbFM4RldHWk91Q3lQQ19KRnM2NlZSRWlwRVRldHdhYkZFZjRWZzd6UWdQRzdkNFAwSm9pak1wamJVN3ZyTHRHazlFVmk1VXhGaz…
INDIAGLYCO — Frequently Asked Questions
What is the current share price of India Glycols Limited (INDIAGLYCO)?
As of 2026-09-08 04:53 IST, India Glycols Limited (INDIAGLYCO) trades at ₹260.40 on NSE. Its 52-week range is ₹236.20 to ₹1,203.30.
What is the market capitalisation of INDIAGLYCO?
India Glycols Limited (INDIAGLYCO) has a market capitalisation of ₹1,745.38 Cr on NSE.
What is the P/E ratio of INDIAGLYCO?
INDIAGLYCO trades at a trailing price-to-earnings (P/E) ratio of 6.98. The industry average P/E is 27.43. Its price-to-book (P/B) ratio is 2.61.
Does INDIAGLYCO pay a dividend?
India Glycols Limited (INDIAGLYCO) currently offers a dividend yield of 1.09%.
What is the return on equity (ROE) of INDIAGLYCO?
INDIAGLYCO has a return on equity (ROE) of 9.98%. Its return on capital employed (ROCE) is 12.07%.
Is INDIAGLYCO a good stock to buy?
This page provides a data-driven analysis of India Glycols Limited (INDIAGLYCO), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.